Cargando…
Promising Effect of High Dose Ambroxol Treatment on Neurocognition and Motor Development in a Patient With Neuropathic Gaucher Disease 2
Gaucher Disease (GD) 2 is a rare inherited lysosomal disorder. Early-onset and rapid progression of neurovisceral symptoms lead to fatal outcome in early childhood. Treatment is symptomatic, a curative therapy is currently not available. This prospective study describes the clinical and biochemical...
Autores principales: | Aries, Charlotte, Lohmöller, Benjamin, Tiede, Stephan, Täuber, Karolin, Hartmann, Guido, Rudolph, Cornelia, Muschol, Nicole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207411/ https://www.ncbi.nlm.nih.gov/pubmed/35734474 http://dx.doi.org/10.3389/fneur.2022.907317 |
Ejemplares similares
-
Use of Ambroxol as Therapy for Gaucher Disease
por: Zhan, Xia, et al.
Publicado: (2023) -
Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study
por: Narita, Aya, et al.
Publicado: (2016) -
Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsy
por: Kim, Yoon-Myung, et al.
Publicado: (2020) -
In vitro and in vivo effects of Ambroxol chaperone therapy in two Italian patients affected by neuronopathic Gaucher disease and epilepsy
por: Ciana, Giovanni, et al.
Publicado: (2020) -
Topical ambroxol for the treatment of neuropathic pain: An initial clinical observation. English version
por: Kern, K.-U., et al.
Publicado: (2015)